Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.
New Treatments for HR-Positive Breast Cancer and Mantle Cell Lymphoma Offer Promising Outcomes and Expanded Options for ...
Since the exact cause is not known, it may not be easy to prevent breast cancer. However, reducing the risks of breast cancer ...
Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.
On January 17, 2025, the Food and Drug Administration (FDA) approved datopotamab deruxtecan-dlnk a Trop-2-directed antibody ...
Beloved TV host Ananda Lewis shares her story and a message to Black women about prioritizing their health in the new year.
Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...
Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.
Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by ...
Dawn Klemow, MD, assistant clinical professor, University of Texas Southwestern Medical Center, previews some of the most recent advances in breast cancer treatment.